📰 Dexcom News
Page 82 - Dexcom News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dexcom. Real-time updates on events, politics, business and more.
April 28, 2024
DexCom (NASDAQ:DXCM – Get Free Report) had its target price lifted by research analysts at Raymond James from $151.00 to $160.00 in a research report issued on Friday, Benzinga reports. The brokerage currently has a “strong-buy” rating on the medical device company’s stock. Raymond James’ price target points to a potential upside of 28.68% from […]
April 28, 2024
DexCom (NASDAQ:DXCM – Get Free Report) released its quarterly earnings data on Thursday. The medical device company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05, reports. DexCom had a return on equity of 31.38% and a net margin of 16.82%. The firm had revenue of $921.00 million […]
April 27, 2024
DexCom (NASDAQ:DXCM – Get Free Report) announced its quarterly earnings results on Thursday. The medical device company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05, reports. The firm had revenue of $921.00 million for the quarter, compared to analyst estimates of $911.20 million. DexCom had a net […]
April 27, 2024
C WorldWide Group Holding A S boosted its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 3.2% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 384,000 shares of the medical device company’s stock after purchasing an additional 12,000 shares during the period. DexCom […]
April 26, 2024
Unveiling the Financial Fortitude and Market Dynamics of DexCom Inc (DXCM)
April 25, 2024
California Public Employees Retirement System decreased its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 3.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 691,682 shares of the medical device company’s stock after selling 25,161 shares during the […]
April 25, 2024
Bailard Inc. reduced its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 15.0% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 55,668 shares of the medical device company’s stock after selling 9,850 shares during the period. Bailard Inc.’s holdings […]
April 25, 2024
Pittenger & Anderson Inc. purchased a new position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 2,813 shares of the medical device company’s stock, valued at approximately $349,000. Several other hedge […]
April 24, 2024
Parkside Financial Bank & Trust raised its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 11.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,086 shares of the medical device company’s stock after acquiring an additional 218 shares during the quarter. […]
April 24, 2024
Linden Thomas Advisory Services LLC grew its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 2.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 13,376 shares of the medical device company’s stock after purchasing an additional […]